Quince Therapeutics (QNCX) Goodwill (2022 - 2024)

Quince Therapeutics (QNCX) posted quarterly Goodwill of $17.2 million for Q1 2024, down 2.16% quarter-over-quarter from $17.6 million in Q4 2023.

Quince Therapeutics (QNCX) Goodwill (2022 - 2024) Analysis & Trends

Quince Therapeutics' Goodwill history runs 3 years deep, the most recent figure standing at $17.2 million for Q1 2024.

In Q1 2024, Goodwill changed N/A year-over-year to $17.2 million; the TTM figure through Mar 2024 stood at $17.2 million (changed N/A YoY), while the FY2023 annual figure was $17.6 million, changed N/A from the prior year.
Goodwill for Q1 2024 stood at $17.2 million, down from $17.6 million in the prior quarter.
The five-year high for Goodwill was $17.6 million in Q4 2023, with the low at $825000.0 in Q2 2022.
The 3-year median for Goodwill is $17.2 million (2024), against an average of $11.9 million.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Quince Therapeutics	203.43 Mn	203.43 Mn	-

Download Data